London, United Kingdom

Robert G Cooper


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert G Cooper: A Pioneer in Biochemical Engineering

Introduction

Robert G Cooper is a distinguished inventor based in London, GB. With a keen focus on the field of biochemical engineering, he is recognized for his innovative contributions that bridge the gap between chemistry and biology. His patent portfolio highlights his commitment to advancing scientific knowledge and applications.

Latest Patents

Among his notable achievements, Robert G Cooper holds a patent for "Polycationic sterol derivatives as transfection agents." This innovative compound is capable of acting as a cationic lipid, comprising a cholesterol group linked with a head group that exhibits a more positive charge than the head group of DC-Chol. This breakthrough has significant implications for gene delivery and transfection methods in biotechnology.

Career Highlights

Robert G Cooper has made substantial strides in his career, particularly through his association with Ic-Vec Limited. His work there emphasizes the application of his patented technologies in real-world scenarios, contributing to advancements in the pharmaceutical and biotech industries. His expertise in synthesizing novel compounds has positioned him as a respected figure within his field.

Collaborations

Throughout his career, Robert has collaborated with several talented individuals, including Andrew David Miller and Christopher J Etheridge. These partnerships not only enhance his innovative capabilities but also foster an environment of shared knowledge and creativity, ultimately leading to more successful inventions and applications.

Conclusion

Robert G Cooper's contributions to the field of biochemical engineering exemplify the spirit of innovation and collaboration. His patented work on polycationic sterol derivatives as transfection agents demonstrates his dedication to advancing scientific research. As he continues his work with Ic-Vec Limited, the potential for future discoveries remains promising, paving the way for significant advancements in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…